Argenica Therapeutics Ltd (AU:AGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Geoff Pocock, a director at Argenica Therapeutics Limited, has indirectly adjusted his interest in the company by exercising options and cancelling others in lieu of payment. Pocock utilized a cashless exercise mechanism, converting 294,239 options into ordinary shares and cancelling an additional 205,761 options to cover the exercise proceeds, resulting in a total holding of 4,730,929 fully paid ordinary shares after the transaction.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.